Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Trading Statement

29 Jan 2025 07:00

RNS Number : 0323V
FDM Group (Holdings) plc
29 January 2025
 

29 January 2025

FDM GROUP (HOLDINGS) PLC ("FDM GROUP", "FDM" or "THE GROUP")

YEAR END TRADING UPDATE

FDM Group, a global professional services provider with a focus on Information Technology, today provides a trading update for the year to 31 December 2024, ahead of its full year results, which will be released on 19 March 2025.

Group Trading in the Period and Closing Balance Sheet

The Board anticipates that the Group's financial performance for the year to 31 December 2024 will be in line with its expectations.

Against a continuing backdrop of very challenging market conditions, the Group delivered a resilient performance in 2024. Throughout the period the Board maintained its focus on realigning recruitment, training, Consultant resource, and internal staffing levels to better match with the market conditions; this included a reduced number of training completions during the year (2024: 877 training completions; 2023: 1,338 training completions) and a reduction in internal headcount of approximately 30%.

Revenue for the year to 31 December 2024 is expected to be £258 million, down 23% in comparison to the prior year (2023: £334 million). On a constant currency basis revenue decreased by 21%, or £70 million.

The Group ended the year with 2,578 Consultants placed with clients (2023: 3,892) - a lower level of Consultants deployed than previously anticipated. The UK closed with 1,056 Consultants deployed (2023: 1,411); North America closed with 742 Consultants deployed (2023: 1,322); APAC closed with 524 Consultants deployed (2023: 832); and EMEA closed with 256 Consultants deployed (2023: 327). As at 28 January 2025 the Group has 2,626 Consultants placed with clients.

The Group's balance sheet remains robust with closing cash balances of £41 million (2023: £47 million), and cash conversion strong at 120% (2023: 112%). The Group has no debt.

Outlook

Rod Flavell, Group CEO, commented:

"We anticipate that market conditions will remain uncertain during 2025, and it is difficult to predict when they might demonstrate signs of a sustained improvement. While we continue to see encouraging levels of engagement with clients, it is unclear how soon clients' hiring budgets will be released to enable a recovery in our major end markets. Consequently, the Board will continue to take the appropriate measures to adjust recruitment, training, and staffing levels to align with market conditions and seek to optimise the performance of the Group for all of our stakeholders.

As noted above, we opened 2025 with a lower level of Consultants deployed than we had previously anticipated and this, taken with current market conditions, leads the Board to anticipate that the 2025 full year financial performance may be below its previous expectations.

FDM is a robust and agile business, with a strong balance sheet and experienced management team and Board, operating in fundamentally strong markets. The Board remains confident that our business is well positioned to return to growth as and when market conditions improve."

 

 

 

ENDS

For further information please contact:

FDM Group

Rod Flavell - Chief Executive Officer

Mike McLaren - Chief Financial Officer

Mark Heather - Group Governance Director & Company Secretary

 

 

Tel: +44 (0)20 3056 8240

 

Financial PR

Nick Oborne

 

Tel: +44 (0)7850 127526

 

Forward-Looking Statements

This trading update may contain statements which constitute 'forward-looking statements'. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. Subject to any requirement under the Disclosure Guidance and Transparency Rules or other applicable legislation, regulation or rules, the Group does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Neither shareholders nor prospective shareholders should place undue reliance on forward-looking statements, which speak only as of the date of this Trading Update.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBPMTTMTBTTLA
Date   Source Headline
12th Mar 20255:25 pmRNSDirector/PDMR Shareholding
4th Mar 20254:34 pmRNSHolding(s) in Company
10th Feb 20257:00 amRNSHolding(s) in Company
6th Feb 20255:59 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:26 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
30th Jan 202512:42 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNSTrading Statement
9th Jan 20255:33 pmRNSDirector/PDMR Shareholding
4th Dec 20244:49 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20247:00 amRNSTrading Update
7th Nov 20243:58 pmRNSDirector/PDMR Shareholding
1st Nov 20247:47 amRNSTotal Voting Rights
9th Oct 20245:30 pmRNSDirector/PDMR Shareholding
1st Oct 202411:30 amRNSTotal Voting Rights
11th Sep 20245:16 pmRNSDirector/PDMR Shareholding
11th Sep 20244:50 pmRNSNotification of Transactions of Directors & PDMRs
2nd Sep 20247:00 amRNSTotal Voting Rights
13th Aug 202412:00 pmRNSDirector/PDMR Shareholding
1st Aug 20241:33 pmRNSPDMR Shareholding
1st Aug 20241:30 pmRNSPDMR Shareholding
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:04 pmRNSAppointment of Joint Corporate Broker
31st Jul 20247:00 amRNSHalf-year Report
11th Jul 20242:58 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSTotal Voting Rights
13th Jun 202411:45 amRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:36 pmRNSDirector/PDMR Shareholding
29th May 20249:37 amRNSDirector/PDMR Shareholding
15th May 20244:13 pmRNSDirectorate Change
14th May 20244:34 pmRNSResult of AGM
14th May 20247:00 amRNSAGM Statement
10th May 20241:48 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
29th Apr 20248:00 amRNSDirector Declaration
12th Apr 20247:14 amRNSDirector/PDMR Shareholding
9th Apr 202412:00 pmRNSNotice of 2024 Annual General Meeting
2nd Apr 20249:00 amRNSTotal Voting Rights
20th Mar 20248:20 amRNSPreliminary Results
8th Mar 202412:24 pmRNSDirector/PDMR Shareholding
1st Mar 202410:39 amRNSTotal Voting Rights
13th Feb 20241:05 pmRNSDirector Declaration
7th Feb 20243:18 pmRNSDirector/PDMR Shareholding
5th Feb 20242:02 pmRNSHolding(s) in Company
1st Feb 20249:57 amRNSTotal Voting Rights
31st Jan 20245:00 pmRNSDirector Declaration
31st Jan 20247:00 amRNSYear End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.